Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21906289 | 0.85 | MEN1 (0.36) | TSHRMEN1KMT2A | |
| SCHEMBL13575585 | 0.79 | TP53 (0.48) | TSHRTP53TDP1MEN1KMT2A | |
| SCHEMBL8928315 | 0.79 | TP53 (0.48) | TSHRTP53TDP1MEN1KMT2A | |
| SCHEMBL12233058 | 0.75 | — | — | |
| SCHEMBL15443801 | 0.70 | TSHR (0.37) | TSHRTP53TDP1MEN1KMT2A | |
| SCHEMBL13675404 | 0.69 | — | — | |
| SCHEMBL14654989 | 0.69 | TSHR (0.36) | TSHRTP53TDP1MEN1KMT2A | |
| SCHEMBL29610716 | 0.69 | TSHR (0.40) | TSHRTP53TDP1MEN1KMT2A | |
| SCHEMBL5623197 | 0.69 | TP53 (0.42) | TSHRTP53TDP1MEN1KMT2A | |
| SCHEMBL29389309 | 0.66 | KMT2A (0.58) | TSHRTP53TDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200144672-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH PHOSPHORUS CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-05-07 | — | — | US | claimed |
| US-20240356083-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH PHOSPHORUS CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORP (US) | 2024-10-24 | — | — | US | disclosed |
| US-11961967-B2 | Silicon-based energy storage devices with phosphorus containing electrolyte additives | ENEVATE CORPORATION (US) | 2024-04-16 | — | — | US | disclosed |
| WO-2023046060-A9 | TREATMENT OF CANCER PATIENTS HAVING KRAS MUTATIONS | 深圳艾欣达伟医药科技有限公司 | 2023-08-31 | — | — | WO | disclosed |
| US-20230257449-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLUENZA | VISTERRA INC (US) | 2023-08-17 | — | — | US | disclosed |
| EP-4206209-A1 | DEUTERATED COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Ascentawits Pharmaceuticals, Ltd. (CN) | 2023-07-05 | — | — | EP | disclosed |
| WO-2023082354-A1 | DEUTERATED COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 深圳艾欣达伟医药科技有限公司 | 2023-05-19 | — | — | WO | disclosed |
| CN-115551885-A | Compositions and methods for treating and preventing influenza | 威特拉公司 | 2022-12-30 | — | — | CN | disclosed |
| EP-4073107-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLUENZA | Visterra, Inc. (US) | 2022-10-19 | — | — | EP | disclosed |
| WO-2020228685-A9 | FLUORINE-CONTAINING COMPOUND AND ANTI-CANCER MEDICAL USE THEREOF | 深圳艾欣达伟医药科技有限公司 | 2021-02-18 | — | — | WO | disclosed |
| WO-2020228685-A1 | FLUORINE-CONTAINING COMPOUND AND ANTI-CANCER MEDICAL USE THEREOF | 深圳艾欣达伟医药科技有限公司 | 2020-11-19 | — | — | WO | disclosed |
| US-20200144672-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH PHOSPHORUS CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-05-07 | — | — | US | disclosed |
| US-20200144672-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH PHOSPHORUS CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-05-07 | — | — | US | disclosed |